# Dipasa USA, Inc - Inspection Records

Source: https://www.keypedia.com/companies/dipasa-usa-inc/7fdb3bf3-c707-44a2-a1f3-9c7777a31f4d

> Inspection records and compliance data for Dipasa USA, Inc in Brownsville, Texas. Access full analysis and detailed observations.

---

## Details

- Name: Dipasa USA, Inc
- FEI Number: 1000138625
- City: Brownsville
- State: Texas
- Country Name: United States
- Address Line 1: 6600 E. Fm 802
- Zip Code: 78526

## Related Documents

- [FDA Inspection 1299174 - Dipasa USA, Inc - 2026-01-14](https://www.keypedia.com/records/fda_inspections/dipasa-usa-inc/c4b4af69-c312-4c9b-809a-01cf841cf487) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 14, 2026
- [FDA Inspection 1299174 - Dipasa USA, Inc - 2026-01-14](https://www.keypedia.com/records/fda_inspections/dipasa-usa-inc/acf23e65-1f41-4ae3-b404-f3086e03c064) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 14, 2026
- [FDA Inspection 1299174 - Dipasa USA, Inc - 2026-01-14](https://www.keypedia.com/records/fda_inspections/dipasa-usa-inc/caac2e2c-2734-4b88-a6c6-e691dee24349) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 14, 2026
- [483 - Dipasa USA, Inc - 2023-09-06](https://www.keypedia.com/records/483/dipasa-usa-inc/fc27b50e-c3e3-4579-9731-f9a511117b30) — source: FDA, date: September 6, 2023
- [FDA Inspection 1217360 - Dipasa USA, Inc - 2023-09-06](https://www.keypedia.com/records/fda_inspections/dipasa-usa-inc/3cbacf2b-f728-41ed-9d46-111edaec7332) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 6, 2023
- [FDA Inspection 1217360 - Dipasa USA, Inc - 2023-09-06](https://www.keypedia.com/records/fda_inspections/dipasa-usa-inc/47f80d85-4358-437d-964d-3081286702f4) — classification: No Action Indicated (NAI), source: FDA, date: September 6, 2023
- [FDA Inspection 1148606 - Dipasa USA, Inc - 2021-07-30](https://www.keypedia.com/records/fda_inspections/dipasa-usa-inc/166153f3-fdd4-46bb-885e-32b316ba4e4c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 30, 2021
- [FDA Inspection 1054903 - Dipasa USA, Inc - 2018-05-04](https://www.keypedia.com/records/fda_inspections/dipasa-usa-inc/27b4eeb7-2308-4f23-9a71-368bd1733e36) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 4, 2018
- [FDA Inspection 785304 - Dipasa USA, Inc - 2012-06-07](https://www.keypedia.com/records/fda_inspections/dipasa-usa-inc/42e723b3-78b2-4cb2-9397-35e9c068d241) — classification: No Action Indicated (NAI), source: FDA, date: June 7, 2012

## Related Companies

- [Edwards Lifesciences, LLC](https://www.keypedia.com/companies/edwards-lifesciences-llc/3f203202-b877-45c5-893a-0bc4dee86605)
- [Fisher Wallace Laboratories Inc.](https://www.keypedia.com/companies/fisher-wallace-laboratories-inc/24abbbef-09e9-4340-a506-834ecb394e59)
- [Wells Enterprises, Inc.](https://www.keypedia.com/companies/wells-enterprises-inc/eecae644-b8fd-4b93-a19e-cb8622c3186d)
- [Pace Analytical Life Sciences](https://www.keypedia.com/companies/pace-analytical-life-sciences/7655da13-95c9-4bd0-ab51-757bdcf43ca2)
- [DePuy Orthopaedics, Inc.](https://www.keypedia.com/companies/depuy-orthopaedics-inc/19905de5-7a2b-44bb-9260-5780437c1eac)
- [Glanbia Nutritionals, Inc.](https://www.keypedia.com/companies/glanbia-nutritionals-inc/17591734-8491-42e8-bff1-957ee35520d9)
- [IVF Laboratory of Central Florida LLC](https://www.keypedia.com/companies/ivf-laboratory-of-central-florida-llc/a3ff8eb3-156c-47a7-9871-089f1f82f703)
- [ConMed Corporation](https://www.keypedia.com/companies/conmed-corporation/ab83684d-062e-47ad-9694-df520179a67e)
- [Analogic Corporation](https://www.keypedia.com/companies/analogic-corporation/e833b34e-cb3b-4b19-ac2f-8ae91b12d33f)
- [Angiodynamics, Inc.](https://www.keypedia.com/companies/angiodynamics-inc/cabf05c2-1177-4dba-93a3-ba8e56e956d6)

## Related Officers

- [investigator](https://www.keypedia.com/people/khunnathee-stoner/99f5003c-94aa-4186-8f8a-74aac21a1f4e)